Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Mueller

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 31, 2011
[Malaria prevention in travellers to malaria-endemic regions]E A Mueller, G Neumann
Journal of Molecular and Cellular Cardiology|February 1, 1977
Lysosomal enzymes in the development and regression of myocardial hypertrophy induced by systemic hypertensionK Wildenthal, E A Mueller
Deutsche Medizinische Wochenschrift (1946)|September 26, 2013
[Levamethadone as substitution treatment of opioid-dependent patients]E A Mueller, W Kirch
Deutsche Medizinische Wochenschrift (1946)|January 14, 2012
[Early benefit evaluation of drugs: procedure and bases for decision-making]E A Mueller, W Kirch
Nature|May 31, 1974
Increased myocardial cathepsin D activity during regression of thyrotoxic cardiac hypertrophyK Wildenthal, E A Mueller
Cancer Research|June 15, 1990
Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognitionE A Mueller, F A Anderer
Immunopharmacology|January 1, 1990
Chemical specificity of effector cell/tumor cell bridging by a Viscum album rhamnogalacturonan enhancing cytotoxicity of human NK cellsE A Mueller, F A Anderer
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducerE A Mueller, F A Anderer
Transplantation Proceedings|September 2, 1998
Cyclosporine microemulsion formulation (Neoral) in transplantation: pharmacokinetic/pharmacodynamic relationshipsE A Mueller, D Niese, B Mellein
Transplantation Proceedings|December 1, 1994
Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patientsS Taesch, D Niese, E A Mueller
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
Deutsche Medizinische Wochenschrift (1946)|March 31, 2011
[Malaria prevention in travellers to malaria-endemic regions]E A Mueller, G Neumann
Journal of Molecular and Cellular Cardiology|February 1, 1977
Lysosomal enzymes in the development and regression of myocardial hypertrophy induced by systemic hypertensionK Wildenthal, E A Mueller
Deutsche Medizinische Wochenschrift (1946)|September 26, 2013
[Levamethadone as substitution treatment of opioid-dependent patients]E A Mueller, W Kirch
Deutsche Medizinische Wochenschrift (1946)|January 14, 2012
[Early benefit evaluation of drugs: procedure and bases for decision-making]E A Mueller, W Kirch
Nature|May 31, 1974
Increased myocardial cathepsin D activity during regression of thyrotoxic cardiac hypertrophyK Wildenthal, E A Mueller
Cancer Research|June 15, 1990
Synergistic action of a plant rhamnogalacturonan enhancing antitumor cytotoxicity of human natural killer and lymphokine-activated killer cells: chemical specificity of target cell recognitionE A Mueller, F A Anderer
Immunopharmacology|January 1, 1990
Chemical specificity of effector cell/tumor cell bridging by a Viscum album rhamnogalacturonan enhancing cytotoxicity of human NK cellsE A Mueller, F A Anderer
Cancer Immunology, Immunotherapy : CII|January 1, 1990
A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducerE A Mueller, F A Anderer
Transplantation Proceedings|September 2, 1998
Cyclosporine microemulsion formulation (Neoral) in transplantation: pharmacokinetic/pharmacodynamic relationshipsE A Mueller, D Niese, B Mellein
Transplantation Proceedings|December 1, 1994
Sandimmun neoral, a new oral formulation of cyclosporin A with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patientsS Taesch, D Niese, E A Mueller
Pageof 10